Associates
William C. Eckelman
Dr. William C. Eckelman is Adjunct Professor at UCSD, Chair of the Scientific Advisory Board at Molecular Insight Pharmaceuticals, Inc., and the president of Molecular Tracer LLC. During his career, he has developed “instant kits” which became the basis for all subsequent 99mTc radiopharmaceutical kits; performed the first neuroreceptor image in humans in 1983; obtained and presented in 1984 the first definitive positron emission tomography image of opioid receptor occupancy in primate brain; led the research group that developed the strontium-82/rubidium-82 generator, 99mTc labeled teboroxime, and Prohance, a gadolinium labeled MRI contrast agent, and other receptor binding radiotracers; and developed techniques to use non-traditional PET radionuclides such as Tc-94m, Br-76, Ga-66, Y-86, and I-124. In addition to his research efforts, Dr. Eckelman has been the editor-in-chief of Nuclear Medicine and Biology. He received the Herman L. Blumgart Pioneer Lecture Award, the Paul C. Aebersold Award for Outstanding Achievement in Basic Science Applied to Nuclear Medicine, the American College of Nuclear Physicians Corporate Achievement Award, the Georg deHevesy Nuclear Pioneer Award, and the Great Golden Seal of Padua University in recognition of contributions to Radiopharmaceutical Development. He has published over 400 research papers, books and book chapters.